Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 11 Apr 2025
A study links daily discrimination to greater depression and anxiety rates, with marginalized groups facing greater mental health risks across the US.
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
How access to specialized cancer centers affects glioblastoma outcomes
2.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
3.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
4.
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain
5.
Beyond What Is Visible in Myelofibrosis?
1.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
2.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
3.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
4.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
5.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Modern Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge